Yvette L Kasamon

5PUBLICATIONS
33CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Liquid biopsiesMedical bacteriology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Oct 15, 2024
FDA Approval Summary: Polatuzumab Vedotin in the First-Line Treatment of Select Large B-Cell Lymphomas.

Maryam Sarraf Yazdy, Yvette L Kasamon, Wenjuan Gu

|Feb 07, 2024
FDA Approval Summary: Lisocabtagene Maraleucel for Second-Line Treatment of Large B-Cell Lymphoma.

Mona Elmacken, Helkha Peredo-Pinto, Cong Wang

|Aug 25, 2023
FDA Approval Summary: Pirtobrutinib for Relapsed or Refractory Mantle Cell Lymphoma.

Deepti Telaraja, Yvette L Kasamon, Justin S Collazo

|Jul 05, 2023
FDA Approval Summary: Axicabtagene Ciloleucel for Second-Line Treatment of Large B-Cell Lymphoma.

Poornima Sharma, Yvette L Kasamon, Xue Lin

|Mar 09, 2023
Minimal Residual Disease Data in Hematologic Malignancy Drug Applications and Labeling: An FDA Perspective.

Andrea C Baines, Maryam Sarraf Yazdy, Yvette L Kasamon

Pageof 1

Frequent Collaborators

5 joint publications

Marc R Theoret

3 joint publications

Nicole J Gormley

2 joint publications

Maryam Sarraf Yazdy

2 joint publications

Lisa R Rodriguez